Trial Profile
Pivotal phase III European trial of MF 101 in women with hot flashes associated with menopausal syndrome
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 30 Jul 2010
Price :
$35
*
At a glance
- Drugs MF 101 (Primary)
- Indications Hot flashes; Menopausal syndrome
- Focus Registrational; Therapeutic Use
- Sponsors Bionovo
- 30 Jul 2010 New trial record